The story of this 45 year old Delhi man is about the fragile line between information and treatment, convenience and care, technology and responsibility.... Feb 07
The deaths discussed in the Assembly, however few in number, should prompt reflection rather than defensiveness... Feb 06
Licensing authorities will need trained personnel, clear evaluation criteria, and efficient review processes to handle submissions without causing unnecessary delays... Feb 06
The story of this 45 year old Delhi man is about the fragile line between information and treatment, convenience and care, technology and responsibility.... Feb 03
Training pharmacists, informing doctors, and educating patients will determine whether this policy delivers real-world impact or remains a rule on paper.... Jan 29
Drug quality is not a peripheral issue reserved for regulators and manufacturers. It is central to patient safety, clinical outcomes, and the credibility of the ... Jan 23
From the moment raw materials are sourced to the time a syrup bottle reaches a patient’s hand, there must be no blind spots. A ... Nov 11
Regulatory bodies must act with transparency, manufacturers must uphold integrity, and hospitals must maintain vigilance because behind every batch number is a child whose life ... Oct 18
As India observes the aftermath of yet another preventable disaster, one can only hope that this time, the outrage translates into reform.... Oct 14
The syrups under scrutiny may have been pulled from shelves, but the real cure lies in building a culture of accountability, transparency, and science-backed ... Oct 13
Strengthened pharmacovigilance, faster forensic analysis, stricter licensing of manufacturers, and zero tolerance for sub-standard products must become non-negotiable priorities.... Oct 06
The real measure of a nation’s healthcare system is not how many medicines it produces, but how safe, reliable, and effective those medicines are ... Sep 22
In a country where millions depend on affordable medicines, such safety alerts are lifelines of information and signals that guide the entire healthcare ecosystem. ... Sep 06
As consumers, we must remain vigilant, informed, and proactive in ensuring that the medications we take are truly safe.... Mar 03
Brand Institute, the global leader in pharmaceutical and healthcare-related name development, is proud to announce its role in naming Pfizer and BioNTech's COVID-... Dec 29
InSilicoTrials presents a suite of highly innovative products that could revolutionize the global pharmaceutical industry ... Nov 17
-Advertisements-